IC
MXCT icon

IEQ Capital’s MaxCyte MXCT Stock Holding History

IEQ Capital’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.9K Buy
115,200
+103,075
+850% +$96.2K ﹤0.01% 1816
2025
Q4 		$18.8K Sell
12,125
-8,248
-40% -$13.2K ﹤0.01% 1829
2025
Q3 		$32.2K Buy
20,373
+6,492
+47% +$11.3K ﹤0.01% 1815
2025
Q2 		$30.3K Buy
13,881
+2,804
+25% +$6.79K ﹤0.01% 1785
2025
Q1 		$30.2K Buy
+11,077
New +$43.7K ﹤0.01% 1574

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

IEQ Capital's MXCT Position: Q1 2026 in Review

IEQ Capital increased its MaxCyte (MXCT) stake by 850% in Q1 2026, buying an estimated $96.2K and bringing the position to 115,200 shares worth $80.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

IEQ Capital first reported a position in MXCT in Q1 2025 and has held it in 5 quarters since. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • IEQ Capital held 115,200 shares of MaxCyte worth $80.9K as of Q1 2026.
  • IEQ Capital bought 103,075 MaxCyte shares in Q1 2026, an estimated $96.2K.
  • MaxCyte made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1816 holding.
  • IEQ Capital first reported a position in MaxCyte in Q1 2025 and has held it in 5 quarters since.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.